These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15044558)

  • 1. UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver.
    Court MH; Hao Q; Krishnaswamy S; Bekaii-Saab T; Al-Rohaimi A; von Moltke LL; Greenblatt DJ
    J Pharmacol Exp Ther; 2004 Aug; 310(2):656-65. PubMed ID: 15044558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for oxazepam as an in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion.
    He X; Hesse LM; Hazarika S; Masse G; Harmatz JS; Greenblatt DJ; Court MH
    Br J Clin Pharmacol; 2009 Nov; 68(5):721-30. PubMed ID: 19916996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTs): S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9.
    Court MH; Duan SX; Guillemette C; Journault K; Krishnaswamy S; Von Moltke LL; Greenblatt DJ
    Drug Metab Dispos; 2002 Nov; 30(11):1257-65. PubMed ID: 12386133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of UDP-glucuronosyltransferase 2B15 polymorphism on bisphenol A glucuronidation.
    Hanioka N; Oka H; Nagaoka K; Ikushiro S; Narimatsu S
    Arch Toxicol; 2011 Nov; 85(11):1373-81. PubMed ID: 21404072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: I. Identification of polymorphisms in the 5'-regulatory and exon 1 regions, and association with human liver UGT1A6 gene expression and glucuronidation.
    Krishnaswamy S; Hao Q; Al-Rohaimi A; Hesse LM; von Moltke LL; Greenblatt DJ; Court MH
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1331-9. PubMed ID: 15761114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men.
    Swanson C; Mellström D; Lorentzon M; Vandenput L; Jakobsson J; Rane A; Karlsson M; Ljunggren O; Smith U; Eriksson AL; Bélanger A; Labrie F; Ohlsson C
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4878-82. PubMed ID: 17698910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.
    Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ
    Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UDP-glucuronosyltransferase 2B15 (UGT2B15) is the major enzyme responsible for sipoglitazar glucuronidation in humans: retrospective identification of the UGT isoform by in vitro analysis and the effect of UGT2B15*2 mutation.
    Nishihara M; Hiura Y; Kawaguchi N; Takahashi J; Asahi S
    Drug Metab Pharmacokinet; 2013; 28(6):475-84. PubMed ID: 23648677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of human UDP-glucuronosyltransferases involved in N-carbamoyl glucuronidation of lorcaserin.
    Sadeque AJ; Usmani KA; Palamar S; Cerny MA; Chen WG
    Drug Metab Dispos; 2012 Apr; 40(4):772-8. PubMed ID: 22259019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic glucuronidation of 4-tert-octylphenol in humans: inter-individual variability and responsible UDP-glucuronosyltransferase isoforms.
    Isobe T; Ohkawara S; Tanaka-Kagawa T; Jinno H; Hanioka N
    Arch Toxicol; 2017 Nov; 91(11):3543-3550. PubMed ID: 28500425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation.
    Hanioka N; Naito T; Narimatsu S
    Chemosphere; 2008 Dec; 74(1):33-6. PubMed ID: 18990428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes.
    Yamanaka H; Nakajima M; Katoh M; Kanoh A; Tamura O; Ishibashi H; Yokoi T
    Drug Metab Dispos; 2005 Jan; 33(1):23-30. PubMed ID: 15470160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing the effects of common UDP glucuronosyltransferase (UGT) 1A6 and UGT1A1 polymorphisms on cis- and trans-resveratrol glucuronidation.
    Iwuchukwu OF; Ajetunmobi J; Ung D; Nagar S
    Drug Metab Dispos; 2009 Aug; 37(8):1726-32. PubMed ID: 19406951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (S)oxazepam glucuronidation is inhibited by ketoprofen and other substrates of UGT2B7.
    Patel M; Tang BK; Kalow W
    Pharmacogenetics; 1995 Feb; 5(1):43-9. PubMed ID: 7773302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure.
    Court MH; Freytsis M; Wang X; Peter I; Guillemette C; Hazarika S; Duan SX; Greenblatt DJ; Lee WM;
    J Pharmacol Exp Ther; 2013 May; 345(2):297-307. PubMed ID: 23408116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of the microRNA response elements in the 3'-untranslated region of the UDP glucuronosyltransferase (UGT) 2B7 and 2B15 genes by a functional genomics approach.
    Papageorgiou I; Court MH
    Biochem Pharmacol; 2017 Dec; 146():199-213. PubMed ID: 28962835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphism of UDP-glucuronosyltransferase (UGT2B15) and glucuronidation of paracetamol in healthy population.
    Mehboob H; Iqbal T; Jamil A; Khaliq T
    Pak J Pharm Sci; 2016 May; 29(3 Suppl):1037-41. PubMed ID: 27383482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glucuronidation of R- and S-lorazepam: human liver microsomal kinetics, UDP-glucuronosyltransferase enzyme selectivity, and inhibition by drugs.
    Uchaipichat V; Suthisisang C; Miners JO
    Drug Metab Dispos; 2013 Jun; 41(6):1273-84. PubMed ID: 23554428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucuronidation of anti-HIV drug candidate bevirimat: identification of human UDP-glucuronosyltransferases and species differences.
    Wen Z; Martin DE; Bullock P; Lee KH; Smith PC
    Drug Metab Dispos; 2007 Mar; 35(3):440-8. PubMed ID: 17151190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin by human UDP-glucuronosyltransferase (UGT) 1A1, UGT1A9, and UGT2B15: effects of UGT-UGT interactions.
    Nakajima M; Yamanaka H; Fujiwara R; Katoh M; Yokoi T
    Drug Metab Dispos; 2007 Sep; 35(9):1679-86. PubMed ID: 17576806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.